University of Groningen RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer

Molecular Oncology(2019)

引用 23|浏览3
暂无评分
摘要
RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer van Helden, Erik J.; Angus, Lindsay; van Oordt, C. Willemien Menke-van der Houven; Heideman, Danielle A. M.; Boon, Eline; van Es, Suzanne C.; Radema, Sandra A.; van Herpen, Carla M. L.; de Groot, Derk Jan A.; de Vries, Elisabeth G. E. Published in: Molecular oncology
更多
查看译文
关键词
biomarkers,BRAF,cell‐free DNA,cetuximab,colorectal cancer,RAS mutations
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要